Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 2 (RPL5P2)

Target
RPL5P2
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L5 pseudogene 2 (RPL5P2) is a non-coding genetic element derived from the ribosomal protein L5 gene (RPL5). Pseudogenes like RPL5P2 are genetic sequences similar to known genes but typically lack protein-coding functionality due to the accumulation of mutations or deletion of regulatory regions. RPL5P2 is annotated as a processed pseudogene, meaning it arose by reverse transcription of RPL5 mRNA followed by genomic integration, but it does not contribute to ribosomal function or any known cellular processes. RPL5P2 is not an active gene and does not encode the ribosomal protein L5. The functional gene encoding ribosomal protein L5 is RPL5, which is involved in ribosome assembly and intracellular transport of 5S rRNA. RPL5P2 is one of several pseudogenes for RPL5, and as such, it is not typically considered a therapeutic target, nor associated with molecular functions, disease roles, or interactions relevant to drug discovery. Unlike the functional RPL5 gene, which has roles in ribosome biogenesis, protein synthesis, and has been implicated in diseases such as Diamond-Blackfan anemia and certain cancers, RPL5P2 does not have known biological functions, disease associations, or usage as a biomarker. Pseudogenes seldom produce functional protein products, and RPL5P2 fits this definition; therefore, its inclusion as a therapeutic target would be scientifically incorrect. If you are interested in the functional ribosomal protein L5, please refer to the canonical gene (RPL5), which has well-defined roles in human biology and disease.

Other names
dJ461P17.5RPL5_14_1705RPL5P2

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 2 (RPL5P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 2 (RPL5P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call